PND21 PRODUCT ENHANCEMENTS DECREASE THE INCIDENCE OF INJECTION SITE REACTIONS AND PAIN RESULTING IN IMPROVED ADHERENCE TO THERAPY IN PATIENTS WITH MULTIPLE SCLEROSIS
May 1, 2007, 00:00
10.1016/S1098-3015(10)68820-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)68820-1/fulltext
Title :
PND21 PRODUCT ENHANCEMENTS DECREASE THE INCIDENCE OF INJECTION SITE REACTIONS AND PAIN RESULTING IN IMPROVED ADHERENCE TO THERAPY IN PATIENTS WITH MULTIPLE SCLEROSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68820-1&doi=10.1016/S1098-3015(10)68820-1
First page :
Section Title :
Open access? :
No
Section Order :
609